Free Trial
→ The chokepoint supplier behind SpaceX's $1.75 trillion empire (From Behind the Markets) (Ad)tc pixel Free HKPD Stock Alerts

Hong Kong Pharma Digital Technology (HKPD) Competitors

Hong Kong Pharma Digital Technology logo
$0.68 -0.01 (-1.37%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

HKPD vs. NHTC, CGTL, COSM, EPSM, and SCNX

Should you be buying Hong Kong Pharma Digital Technology stock or one of its competitors? The main competitors of Hong Kong Pharma Digital Technology include Natural Health Trends (NHTC), Creative Global Technology (CGTL), Cosmos Health (COSM), Epsium Enterprise (EPSM), and Scienture (SCNX). These companies are all part of the "wholesale" industry.

How does Hong Kong Pharma Digital Technology compare to Natural Health Trends?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Natural Health Trends (NASDAQ:NHTC) are both small-cap wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, media sentiment, profitability and risk.

10.1% of Natural Health Trends shares are held by institutional investors. 12.9% of Natural Health Trends shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Natural Health Trends had 8 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 8 mentions for Natural Health Trends and 0 mentions for Hong Kong Pharma Digital Technology. Natural Health Trends' average media sentiment score of 0.48 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Natural Health Trends is being referred to more favorably in the news media.

Company Overall Sentiment
Hong Kong Pharma Digital Technology Neutral
Natural Health Trends Neutral

Hong Kong Pharma Digital Technology has a beta of 2.64, suggesting that its stock price is 164% more volatile than the S&P 500. Comparatively, Natural Health Trends has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Natural Health Trends
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Natural Health Trends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hong Kong Pharma Digital Technology$20.31M0.37-$30KN/AN/A
Natural Health Trends$38.25M0.69-$880K-$0.11N/A

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Natural Health Trends' net margin of -3.03%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Natural Health Trends' return on equity.

Company Net Margins Return on Equity Return on Assets
Hong Kong Pharma Digital TechnologyN/A N/A N/A
Natural Health Trends -3.03%-4.88%-2.94%

Summary

Natural Health Trends beats Hong Kong Pharma Digital Technology on 6 of the 11 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Creative Global Technology?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Creative Global Technology (NASDAQ:CGTL) are both small-cap wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, media sentiment, profitability and risk.

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Creative Global Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hong Kong Pharma Digital Technology$20.31M0.37-$30KN/AN/A
Creative Global Technology$21.15M0.88-$13.37MN/AN/A

Company Net Margins Return on Equity Return on Assets
Hong Kong Pharma Digital TechnologyN/A N/A N/A
Creative Global Technology N/A N/A N/A

Hong Kong Pharma Digital Technology has a beta of 2.64, suggesting that its stock price is 164% more volatile than the S&P 500. Comparatively, Creative Global Technology has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500.

In the previous week, Hong Kong Pharma Digital Technology's average media sentiment score of 0.00 equaled Creative Global Technology'saverage media sentiment score.

Company Overall Sentiment
Hong Kong Pharma Digital Technology Neutral
Creative Global Technology Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Creative Global Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Hong Kong Pharma Digital Technology and Creative Global Technology tied by winning 2 of the 4 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Cosmos Health (NASDAQ:COSM) are both small-cap wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, media sentiment, risk and valuation.

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Cosmos Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hong Kong Pharma Digital Technology$20.31M0.37-$30KN/AN/A
Cosmos Health$65.27M0.28-$19.15M-$0.61N/A

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Cosmos Health's net margin of -29.33%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Cosmos Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hong Kong Pharma Digital TechnologyN/A N/A N/A
Cosmos Health -29.33%-43.96%-16.22%

Hong Kong Pharma Digital Technology has a beta of 2.64, meaning that its share price is 164% more volatile than the S&P 500. Comparatively, Cosmos Health has a beta of 5, meaning that its share price is 400% more volatile than the S&P 500.

In the previous week, Cosmos Health's average media sentiment score of 0.27 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the news media.

Company Overall Sentiment
Hong Kong Pharma Digital Technology Neutral
Cosmos Health Neutral

12.6% of Cosmos Health shares are owned by institutional investors. 25.1% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cosmos Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Hong Kong Pharma Digital Technology and Cosmos Health tied by winning 5 of the 10 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Epsium Enterprise?

Epsium Enterprise (NASDAQ:EPSM) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap wholesale companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

In the previous week, Epsium Enterprise had 4 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 4 mentions for Epsium Enterprise and 0 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 0.00 beat Epsium Enterprise's score of -0.23 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the news media.

Company Overall Sentiment
Epsium Enterprise Neutral
Hong Kong Pharma Digital Technology Neutral

Epsium Enterprise has a beta of 1.95, suggesting that its share price is 95% more volatile than the S&P 500. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.64, suggesting that its share price is 164% more volatile than the S&P 500.

Hong Kong Pharma Digital Technology has higher revenue and earnings than Epsium Enterprise.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Epsium Enterprise$5.12M3.49-$1.50MN/AN/A
Hong Kong Pharma Digital Technology$20.31M0.37-$30KN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Epsium Enterprise
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Company Net Margins Return on Equity Return on Assets
Epsium EnterpriseN/A N/A N/A
Hong Kong Pharma Digital Technology N/A N/A N/A

Summary

Hong Kong Pharma Digital Technology beats Epsium Enterprise on 4 of the 6 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Scienture?

Scienture (NASDAQ:SCNX) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap wholesale companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

5.7% of Scienture shares are owned by institutional investors. 21.4% of Scienture shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Scienture presently has a consensus price target of $1.50, suggesting a potential upside of 284.02%. Given Scienture's stronger consensus rating and higher probable upside, equities research analysts clearly believe Scienture is more favorable than Hong Kong Pharma Digital Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scienture
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Scienture's return on equity.

Company Net Margins Return on Equity Return on Assets
ScientureN/A -53.25% -41.55%
Hong Kong Pharma Digital Technology N/A N/A N/A

In the previous week, Scienture had 1 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 1 mentions for Scienture and 0 mentions for Hong Kong Pharma Digital Technology. Scienture's average media sentiment score of 1.19 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Scienture is being referred to more favorably in the media.

Company Overall Sentiment
Scienture Positive
Hong Kong Pharma Digital Technology Neutral

Scienture has a beta of 3.32, suggesting that its stock price is 232% more volatile than the S&P 500. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.64, suggesting that its stock price is 164% more volatile than the S&P 500.

Hong Kong Pharma Digital Technology has higher revenue and earnings than Scienture.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scienture$431.61K36.77-$41.51M-$2.76N/A
Hong Kong Pharma Digital Technology$20.31M0.37-$30KN/AN/A

Summary

Scienture beats Hong Kong Pharma Digital Technology on 9 of the 13 factors compared between the two stocks.

Get Hong Kong Pharma Digital Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for HKPD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HKPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HKPD vs. The Competition

Export
MetricHong Kong Pharma Digital TechnologyWholesale – Drugs & Drug Proprietaries IndustryRetail SectorNASDAQ Exchange
Market Cap$7.43M$7.43M$27.48B$11.87B
Dividend YieldN/AN/A178.36%5.21%
P/E RatioN/AN/A18.2928.48
Price / Sales0.370.375.0260.89
Price / CashN/AN/A17.0636.52
Price / BookN/AN/A5.546.67
Net Income-$30K-$30K$959.38M$332.64M
7 Day Performance2.12%2.12%-0.57%2.01%
1 Month Performance18.42%18.42%4.31%9.19%
1 Year Performance-28.18%-28.18%8.96%39.59%

Hong Kong Pharma Digital Technology Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HKPD
Hong Kong Pharma Digital Technology
N/A$0.68
-1.4%		N/AN/A$7.43M$20.31MN/A19
NHTC
Natural Health Trends
1.0054 of 5 stars		$2.94
+0.3%		N/AN/A$25.22M$39.78MN/A140
CGTL
Creative Global Technology
N/A$1.19
-6.0%		N/AN/A$20.15M$21.15MN/AN/A
COSM
Cosmos Health
0.7945 of 5 stars		$0.38
+6.4%		N/AN/A$19.30M$65.27MN/A100
EPSM
Epsium Enterprise
0.8548 of 5 stars		$1.41
+0.6%		N/AN/A$18.42M$8.45MN/A13

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:HKPD) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel